Category: Ecosystem News

Agilent Announces Purchase of Boulder Facility

By: Colorado BioScience Association   Date: 07/25/2019

Agilent Technologies has announced it is purchasing the building in Boulder where they have been manufacturing therapeutic oligonucleotides (“oligos") for over a decade. This $12 million purchase, alo...

Learn More

Silvergate Pharmaceuticals Merges With CutisPharma To Serve Patients On Opposite Ends of the Spectrum

By: Colorado BioScience Association   Date: 07/10/2019

Silvergate Pharmaceuticals produces pediatric medications, while CutisPharma has served the senior population. They’re bringing their companies together to form Azurity Pharmaceuticals. While it might...

Learn More

Cerapedics Announces Expansion of Colorado Headquarters

By: Colorado BioScience Association   Date: 07/08/2019

WESTMINSTER, Colo., July 8, 2019 /PRNewswire/ -- Cerapedics, a private ortho-biologics company, today announced the expansion of the company's headquarters located in the Denver metropolitan area. Ove...

Learn More

Seven Researchers Named Boettcher Investigators

By: Colorado BioScience Association   Date: 05/28/2019

Newest Class Marks 10th Group Selected Under Webb-Waring Program Back row (l-r): Kara Mould, M. Cecilia Caino, Seonil Kim Front row (l-r): Neelanjan Mukherjee, Robert Dietz, Tara Cepon Robins Not pict...

Learn More

ArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio

By: Colorado BioScience Association   Date: 05/15/2019

BOULDER, Colo., May, 15, 2019 /PRNEWSWIRE/-- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine...

Learn More

Prima-Temp Announces New Leadership, Investment, and CE Mark Certification

By: Colorado BioScience Association   Date: 05/08/2019

BOULDER, Colo., May 3, 2019 /PRNewswire/ -- Boulder, Colorado based Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, announced today that in March, it raised...

Learn More

AdvaMed President and CEO Releases Statement On the House Bill To Repeal the Medical Device Tax

By: Colorado BioScience Association   Date: 04/11/2019

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (H.R. 2207) in t...

Learn More

Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M

By: Colorado BioScience Association   Date: 04/08/2019

Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new...

Learn More

Colorado BioScience Association Applauds Expansion by Novartis Company AveXis to Longmont

By: Colorado BioScience Association   Date: 04/01/2019

April 1, 2019 Background: AveXis, a Novartis company, announced the growth of its global advanced gene therapy manufacturing capacity with the acquisition of an advanced biologics therapy facility in...

Learn More

David Perez Is Leaving Terumo BCT, But He'll Still Be Active In The Bioscience Community

By: Colorado BioScience Association   Date: 03/01/2019

Terumo BCT's CEO David Perez may be retiring, but he isn't leaving the Colorado bioscience community. He sat down with the Denver Business Journal’s James Rodriguez to discuss his successes at Terumo...

Learn More